145 related articles for article (PubMed ID: 11068853)
1. Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis.
Tórsdóttir G; Kristinsson J; Gudmundsson G; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2000 Sep; 87(3):126-30. PubMed ID: 11068853
[TBL] [Abstract][Full Text] [Related]
2. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
[TBL] [Abstract][Full Text] [Related]
3. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
4. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
[TBL] [Abstract][Full Text] [Related]
5. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
Iskra M; Majewski W
Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
[TBL] [Abstract][Full Text] [Related]
6. Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese.
Tungtrongchitr R; Pongpaew P; Phonrat B; Tungtrongchitr A; Viroonudomphol D; Vudhivai N; Schelp FP
J Med Assoc Thai; 2003 Jun; 86(6):543-51. PubMed ID: 12924803
[TBL] [Abstract][Full Text] [Related]
7. Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs.
Iskra M; Majewski W
Int J Clin Lab Res; 1999; 29(2):64-7. PubMed ID: 10436263
[TBL] [Abstract][Full Text] [Related]
8. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.
Przedborski S; Donaldson D; Jakowec M; Kish SJ; Guttman M; Rosoklija G; Hays AP
Ann Neurol; 1996 Feb; 39(2):158-65. PubMed ID: 8967746
[TBL] [Abstract][Full Text] [Related]
9. [Ceruloplasmin and copper in the serum of patients with amyotrophic lateral sclerosis (ALS)].
Domzał T; Radzikowska B
Neurol Neurochir Pol; 1983; 17(3):343-6. PubMed ID: 6646324
[TBL] [Abstract][Full Text] [Related]
10. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations.
Jacobsson J; Jonsson PA; Andersen PM; Forsgren L; Marklund SL
Brain; 2001 Jul; 124(Pt 7):1461-6. PubMed ID: 11408340
[TBL] [Abstract][Full Text] [Related]
11. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.
Nikolić-Kokić A; Stević Z; Blagojević D; Davidović B; Jones DR; Spasić MB
Clin Chem Lab Med; 2006; 44(5):589-93. PubMed ID: 16681429
[TBL] [Abstract][Full Text] [Related]
12. Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients.
Cohen O; Kohen R; Lavon E; Abramsky O; Steiner I
J Neurol Sci; 1996 Nov; 143(1-2):118-20. PubMed ID: 8981308
[TBL] [Abstract][Full Text] [Related]
13. [Neurodegenerative diseases, antioxidative enzymes and copper. A review of experimental research.].
Jóhannesson T; Kristinsson J; Snædal J
Laeknabladid; 2003 Sep; 89(9):659-71. PubMed ID: 16940591
[TBL] [Abstract][Full Text] [Related]
14. A low blood copper concentration is a co-morbidity burden factor in Parkinson's disease development.
Ilyechova EY; Miliukhina IV; Orlov IA; Muruzheva ZM; Puchkova LV; Karpenko MN
Neurosci Res; 2018 Oct; 135():54-62. PubMed ID: 29203265
[TBL] [Abstract][Full Text] [Related]
15. Effects of inflammation on copper antioxidant enzyme levels.
DiSilvestro RA
Adv Exp Med Biol; 1989; 258():253-8. PubMed ID: 2560608
[TBL] [Abstract][Full Text] [Related]
16. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease.
Babu GN; Kumar A; Chandra R; Puri SK; Singh RL; Kalita J; Misra UK
Neurochem Int; 2008 May; 52(6):1284-9. PubMed ID: 18308427
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: relationship to clinical data.
Ihara Y; Mori A; Hayabara T; Kawai M; Namba R; Nobukuni K; Sato K; Kibata M
J Neurol Sci; 1995 Dec; 134(1-2):51-6. PubMed ID: 8747843
[TBL] [Abstract][Full Text] [Related]
18. Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors.
DiSilvestro RA; Goodman J; Dy E; Lavalle G
Breast Cancer Res Treat; 2005 Feb; 89(3):251-5. PubMed ID: 15754123
[TBL] [Abstract][Full Text] [Related]
19. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
20. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.
Radunović A; Porto WG; Zeman S; Leigh PN
Neurosci Lett; 1997 Dec; 239(2-3):105-8. PubMed ID: 9469667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
